Kazimi A J

Avg. Two Year Performance

(5%) Avg. Purchase Return
(2%) Compound
28% Avg. Sale Return
13% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(3%)(8%)(4%)(28%)(5%)
Purchase Success Rate7 of 182 of 181 of 180 of 180 of 18
Average Sale Return(< 1%)39%44%47%28%
Sale Success Rate0 of 11 of 11 of 11 of 11 of 1

Cumberland Pharmaceuticals ...

Drugs » Drug Manufacturers - Other

Chairman and CEO, Director, 10% Owner:

Holdings: 5.7M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--